| References: |
Interleukin-1 Receptor-Associated-Kinase-1/4 Inhibitor is a benzimidazole compound that acts as a cell-permeable, potent selective inhibitor of IL-1 kinases. Shown to exhibit little activity against a panel of 27 other kinases, including, but not limited to, Ick and src. For the detailed information of IRAK-1/4 Inhibitor, the solubility of IRAK-1/4 Inhibitor in water, the solubility of IRAK-1/4 Inhibitor in DMSO, the solubility of IRAK-1/4 Inhibitor in PBS buffer, the animal experiment (test) of IRAK-1/4 Inhibitor, the cell expriment (test) of IRAK-1/4 Inhibitor, the in vivo, in vitro and clinical trial test of IRAK-1/4 Inhibitor, the EC50, IC50,and affinity,of IRAK-1/4 Inhibitor, For the detailed information of IRAK-1/4 Inhibitor, the solubility of IRAK-1/4 Inhibitor in water, the solubility of IRAK-1/4 Inhibitor in DMSO, the solubility of IRAK-1/4 Inhibitor in PBS buffer, the animal experiment (test) of IRAK-1/4 Inhibitor, the cell expriment (test) of IRAK-1/4 Inhibitor, the in vivo, in vitro and clinical trial test of IRAK-1/4 Inhibitor, the EC50, IC50,and affinity,of IRAK-1/4 Inhibitor, Please contact DC Chemicals. |
